UBS AM’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-182,293
Closed -$210K 2820
2022
Q1
$210K Buy
182,293
+81,004
+80% +$132K ﹤0.01% 2668
2021
Q4
$253K Hold
101,289
﹤0.01% 2715
2021
Q3
$519K Hold
101,289
﹤0.01% 2487
2021
Q2
$842K Buy
101,289
+21,170
+26% +$178K ﹤0.01% 2306
2021
Q1
$698K Buy
80,119
+8,902
+12% +$92.1K ﹤0.01% 2258
2020
Q4
$773K Buy
71,217
+8,114
+13% +$100K ﹤0.01% 2110
2020
Q3
$753K Sell
63,103
-5,858
-8% -$78.5K ﹤0.01% 1955
2020
Q2
$1.11M Buy
68,961
+4,644
+7% +$81.1K ﹤0.01% 1751
2020
Q1
$998K Sell
64,317
-5,369
-8% -$115K ﹤0.01% 1695
2019
Q4
$1.71M Buy
69,686
+8,233
+13% +$122K ﹤0.01% 1665
2019
Q3
$634K Buy
61,453
+16,518
+37% +$208K ﹤0.01% 2175
2019
Q2
$564K Buy
44,935
+3,471
+8% +$44.7K ﹤0.01% 2160
2019
Q1
$514K Buy
41,464
+4,832
+13% +$54K ﹤0.01% 2096
2018
Q4
$226K Buy
36,632
+16,832
+85% +$129K ﹤0.01% 2339
2018
Q3
$210K Hold
19,800
﹤0.01% 2429
2018
Q2
$268K Hold
19,800
﹤0.01% 2349
2018
Q1
$351K Buy
19,800
+9,600
+94% +$162K ﹤0.01% 2146
2017
Q4
$128K Hold
10,200
﹤0.01% 2373
2017
Q3
$194K Hold
10,200
﹤0.01% 2270
2017
Q2
$154K Hold
10,200
﹤0.01% 2289
2017
Q1
$175K Buy
+10,200
New +$136K ﹤0.01% 2221
2015
Q3
Sell
-9,000
Closed -$216K 2707
2015
Q2
$216K Buy
+9,000
New +$173K ﹤0.01% 2551
2014
Q4
Sell
-173,800
Closed -$4.71M 2634
2014
Q3
$4.71M Sell
173,800
-59,168
-25% -$1.84M ﹤0.01% 1047
2014
Q2
$7.25M Sell
232,968
-16,897
-7% -$398K 0.01% 948
2014
Q1
$5.69M Sell
249,865
-10,323
-4% -$313K 0.01% 1009
2013
Q4
$5.41M Sell
260,188
-3,882
-1% -$113K 0.01% 990
2013
Q3
$10.6M Buy
264,070
+53,422
+25% +$1.81M 0.01% 789
2013
Q2
$5.93M Buy
+210,648
New +$5.41M 0.01% 917

Other funds holding EPZM